Le Lézard
Classified in: Health, Science and technology
Subjects: TRI, FDA

Aidoc Expands AI Service to X-ray, Receiving FDA 510(k) Clearance for Pneumothorax


NEW YORK, March 30, 2022 /PRNewswire/ -- Aidoc, the leading provider of healthcare AI solutions, today announced that it received FDA 510(k) clearance for its triage and notification of pneumothorax on X-ray exams. A one-stop partner for the enterprise's clinical AI needs, Aidoc's other seven FDA-cleared solutions are already implemented across U.S. health systems, flagging and communicating suspected pathologies in CT exams ? and now have expanded to the high volume X-ray modality.

 

Aidoc Logo

 

Aidoc's newly FDA-cleared solution runs on all X-ray machines including portable ones, and is designed to analyze X-ray images. It automatically flags positive cases of pneumothorax, facilitating physicians to read X-rays in a timely manner.

The ability to quickly identify pneumothorax is imperative as it can worsen rapidly and result in respiratory or cardiac failure. This however is easier said than done, due to the extensive imaging volumes radiologists have to continuously examine. Aidoc's highly accurate AI pneumothorax algorithm addresses this challenge by analyzing X-rays, flagging, and notifying physicians of the suspected findings.

"We're very excited about this important milestone," said Elad Walach, CEO of Aidoc. "This FDA clearance further validates the breadth of our AI platform, going beyond specific AI algorithms to act as a healthcare AI hub for the enterprise's cross-specialty needs. This includes ER, ICU, outpatient centers, inpatient admissions, and the coordination of care and communication among providers. By bringing radiologists and proceduralists to the same AI platform, we enable enhanced collaboration across departments and systems to deliver patients with the right treatment at the right time."

Aidoc's AI platform processes high volumes of scans and images without disrupting the physician's workflow. Existing partners of Aidoc, who add the pneumothorax solution to their portfolio, will not require any additional integration, infrastructure, or maintenance efforts.

About Aidoc

Aidoc (aidoc.com) is the leading provider of artificial intelligence healthcare solutions that empower physicians to expedite patient treatment and enhance efficiencies. Aidoc's AI-driven solutions analyze medical images directly after the patient is scanned, suggesting prioritization of time-sensitive pathologies, as well as notifying and activating multidisciplinary teams to reduce turnaround time, shorten length of stay, and improve overall patient outcomes.

Netanya Stein
WestRay Communications
[email protected] 

SOURCE Aidoc


These press releases may also interest you

at 07:05
Battery Ventures, a global, technology-focused investment firm, announced it has closed its take-private acquisition of field-service workflow company TrueContext, formerly known as ProntoForms. The Canadian software company was officially delisted...

at 07:05
Marti Technologies, Inc. ("Marti" or the "Company") , Türkiye's leading mobility super app, today announced that it has appointed Oguz Erkan as its new Chief Financial Officer ("CFO"), effective May 17, 2024. Oguz Erkan replaces the Company's former...

at 07:05
Precision BioSciences, Inc. , an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion, excision, and elimination, today...

at 07:05
Verdantis, a pioneering leader in AI-powered data solutions, proudly announces the appointment of Kumar Gaurav Gupta as its new Chief Executive Officer (CEO). Taking on the role of CEO he shoulders the responsibility of propelling growth, with a...

at 07:01
The enterprise software market is one of the fastest-growing segments within the IT industry. A Statista report shows that it consistently experiences over 10% year-on-year growth...

at 07:00
XORTX Therapeutics Inc. ("XORTX" or the "Company") , a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, announces that further to its press releases of March 11 and April 30,...



News published on and distributed by: